Association of serum soluble Fas concentrations and mortality of septic patients.


Journal

Enfermedades infecciosas y microbiologia clinica (English ed.)
ISSN: 2529-993X
Titre abrégé: Enferm Infecc Microbiol Clin (Engl Ed)
Pays: Spain
ID NLM: 101777541

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 30 06 2020
accepted: 12 08 2020
entrez: 6 12 2021
pubmed: 7 12 2021
medline: 11 3 2022
Statut: ppublish

Résumé

Scarce data on Fas, one of the main receptors that activates the apoptosis extrinsic pathway, in septic patients exists. Higher blood soluble Fas (sFas) concentrations in non-survivor septic patients compared with survivors have been found in small studies; however, the association of blood sFas concentrations with mortality controlling for sepsis severity has not been stablished due to this small sample size in those studies. Thus, our main objective study was to determine whether an association between blood sFas concentrations and sepsis mortality controlling for sepsis severity exists. We included septic patients in this observational and prospective study carried out in three Spanish Intensive Care Units. We obtained serum samples at sepsis diagnosis sepsis for sFas levels determination. Thirty-day non-surviving patients (n=85) compared to surviving patients (n=151) had higher serum sFas levels (p<0.001). We found in multiple logistic regression analysis an association of serum sFas levels with mortality controlling for age and SOFA (OR=1.004; 95% CI=1.002-1.006; p<0.001), and for age and APACHE-II (OR=1.004; 95% CI=1.002-1.006; p<0.001). Serum sFas levels showed and area under the curve for mortality prediction of 71% (95% CI=65-71%; p<0.001). Kaplan-Meier analysis showed higher mortality rate in patients with serum sFas levels>83.5ng/mL (Hazard ratio=3.2; 95% CI=2.1-5.0; p<0.001). That an association between blood sFas concentrations and sepsis mortality controlling for sepsis severity exists was our main new finding study.

Identifiants

pubmed: 34865710
pii: S2529-993X(21)00221-5
doi: 10.1016/j.eimce.2020.08.007
pii:
doi:

Substances chimiques

FAS protein, human 0
fas Receptor 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

493-497

Informations de copyright

Copyright © 2020 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Leonardo Lorente (L)

Intensive Care Unit, Hospital Universitario de Canarias, Ofra, s/n., La Laguna, Tenerife, Spain. Electronic address: lorentemartin@msn.com.

María M Martín (MM)

Intensive Care Unit, Hospital Universitario Nuestra Señora Candelaria, Crta Rosario s/n., Santa Cruz Tenerife, Spain.

Raquel Ortiz-López (R)

Intensive Care Unit, Hospital General de La Palma, Buenavista de Arriba s/n, Breña Alta, La Palma, Spain.

Agustín F González-Rivero (AF)

Laboratory Department, Hospital Universitario de Canarias, Ofra, s/n., La Laguna, Santa Cruz de Tenerife, Spain.

Antonia Pérez-Cejas (A)

Laboratory Department, Hospital Universitario de Canarias, Ofra, s/n., La Laguna, Tenerife, Spain.

Eduardo Pastor (E)

Intensive Care Unit, Hospital Universitario de Canarias, Ofra, s/n., La Laguna, Santa Cruz de Tenerife, Spain.

Claudia Domínguez-Curell (C)

Intensive Care Unit, Hospital Universitario de Canarias, Ofra, s/n., La Laguna, Santa Cruz de Tenerife, Spain.

Lorena Raja (L)

Intensive Care Unit, Hospital Universitario de Canarias, Ofra, s/n., La Laguna, Santa Cruz de Tenerife, Spain.

Lisset Lorenzo (L)

Intensive Care Unit, Hospital Universitario de Canarias, Ofra, s/n., La Laguna, Santa Cruz de Tenerife, Spain.

Alejandro Jiménez (A)

Research Unit, Hospital Universitario de Canarias, Ofra, s/n., La Laguna, Tenerife, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH